Simultaneous pharmacokinetic model for rolofylline and both M1-trans and M1-cis metabolites.
Rolofylline is a potent, selective adenosine A1 receptor antagonist that was under development for the treatment of patients with acute congestive heart failure and renal impairment. Rolofylline is metabolized primarily to the pharmacologically active M1-trans and M1-cis metabolites (metabolites) by cytochrome P450 (CYP) 3A4. The aim of this investigation was to provide a pharmacokinetic (PK) model for rolofylline and metabolites following intravenous administration to healthy volunteers. Data included for this investigation came from a randomized, double-blind, dose-escalation trial in four groups of healthy volunteers (N=36) where single doses of rolofylline, spanning 1 to 60 mg ,were infused over 1-2 h. The rolofylline and metabolite data were analyzed simultaneously using NONMEM. The simultaneous PK model comprised, in part, a two-compartment linear PK model for rolofylline, with estimates of clearance and volume of distribution at steady-state of 24.4 L/h and 239 L, respectively. In addition, the final PK model contained provisions for both conversion of rolofylline to metabolites and stereochemical conversion of M1-trans to M1-cis. Accordingly, the final model captured known aspects of rolofylline metabolism and was capable of simultaneously describing the PK of rolofylline and metabolites in healthy volunteers.
Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA. horstkram@yahoo.com
Mark
M
Stroh
Matthew M
MM
Hutmacher
Jianmei
J
Pang
Ryan
R
Lutz
Hiroshi
H
Magara
Julie
J
Stone
D058916:Adenosine A1 Receptor Antagonists / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D000293:Adolescent; D000328:Adult; D001711:Biotransformation; D051544:Cytochrome P-450 CYP3A / Q000378:metabolism; D004311:Double-Blind Method; D006801:Humans; D007262:Infusions, Intravenous; D016014:Linear Models; D008297:Male; D008657:Metabolic Clearance Rate; D008954:Models, Biological; D014970:Xanthines / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D055815:Young Adult
D058916:Adenosine A1 Receptor Antagonists; D014970:Xanthines; C073525:rolofylline; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human